Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 3/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15927988 | 0.89 | ALDH1A1 (0.50) | NAAAALDH1A1MAPTATMNPSR1 | |
| SCHEMBL1455543 | 0.89 | ALDH1A1 (0.50) | NAAAALDH1A1MAPTATMNPSR1 | |
| SCHEMBL13147735 | 0.89 | ALDH1A1 (0.50) | NAAAALDH1A1MAPTATMNPSR1 | |
| Undecane SCHEMBL20583171 | 0.86 | NAAA (0.57) | NAAAALDH1A1MAPTATMNPSR1 | |
| SCHEMBL17078359 | 0.85 | LMNA (0.44) | NAAAALDH1A1MAPTATMNPSR1 | |
| SCHEMBL5907623 | 0.84 | NAAA (0.59) | NAAAALDH1A1MAPTNPSR1MAPK1 | |
| SCHEMBL28676181 | 0.84 | NAAA (0.59) | NAAAALDH1A1MAPTNPSR1MAPK1 | |
| SCHEMBL4567206 | 0.83 | CYP19A1 (0.34) | — | |
| SCHEMBL22259694 | 0.82 | MGAM (0.41) | ALDH1A1MAPTTSHRLMNA | |
| SCHEMBL5907696 | 0.82 | NAAA (0.62) | NAAAMAPTNPSR1MAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255059-B2 | Method for producing an alkyl 3-hydroxybutyrate | EASTMAN CHEMICAL COMPANY (US) | 2016-02-09 | — | — | US | disclosed |
| WO-2015017177-A1 | METHOD FOR PRODUCING AN ALKYL 3-HYDROXYBUTYRATE | EASTMAN CHEMICAL COMPANY (US) | 2015-02-05 | — | — | WO | disclosed |
| US-20150038734-A1 | METHOD FOR PRODUCING AN ALKYL 3-HYDROXYBUTYRATE | EASTMAN CHEMICAL COMPANY (US) | 2015-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038734-A1 | METHOD FOR PRODUCING AN ALKYL 3-HYDROXYBUTYRATE | HSD17B10, ABAT, HSD17B12 | NAAA 158/4885ALDH1A1 159/4885MAPT 2112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.